Clinical Trials Update: Aug. 30, 2006
Vaccines Peripheral Arterial Occlusive Disease Fibromyalgia
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study will examine the safety and effectiveness of a meningitis vaccine (Menactra) when given at the same time as the standard diphtheria, tetanus, pertussis vaccine (Daptacel) in children 4-6 years old. Your child may be eligible for the study if your child is healthy and has no history of serious medical problems and has not yet received his/her fifth booster dose of diphtheria, tetanus, pertussis vaccine.
Research sites are located throughout the United States.
Peripheral Arterial Occlusive Disease
This study will evaluate the safety and effectiveness of the study drug intra-thrombus alfimeprase 0.3mg/kg compared with a non-medicinal placebo in people with acute peripheral arterial occlusion (PAO). Volunteers must be 18 or older with arteriographically-confirmed acute PAO of the lower extremity with onset of symptoms within 14 days, must not have a history of significant acute or chronic kidney disease that would preclude contrast angiography, and must not have a known allergy to contrast agents.
The research site is in Little Rock, Ark.
If you have pain associated with fibromyalgia, you may be eligible for this research study of an investigational medication. Qualified candidates 18-70 will receive study-related examinations, lab work, and study medication at no cost, and may be eligible for travel expense compensation.
The research site is in Columbus, Ohio.
Copyright 2006 Thomson CenterWatch. All rights reserved.